Literature DB >> 17019729

Carcinogenicity study of GSM and DCS wireless communication signals in B6C3F1 mice.

Thomas Tillmann1, Heinrich Ernst, Sven Ebert, Niels Kuster, Wolfgang Behnke, Susanne Rittinghausen, Clemens Dasenbrock.   

Abstract

The purpose of this study using a total of 1170 B6C3F1 mice was to detect and evaluate possible carcinogenic effects in mice exposed to radio-frequency-radiation (RFR) from Global System for Mobile Communication (GSM) and Digital Personal Communications System (DCS) handsets as emitted by handsets operating in the center of the communication band, that is, at 902 MHz (GSM) and 1747 MHz (DCS). Restrained mice were exposed for 2 h per day, 5 days per week over a period of 2 years to three different whole-body averaged specific absorption rate (SAR) levels of 0.4, 1.3, 4.0 mW/g bw (SAR), or were sham exposed. Regarding the organ-related tumor incidence, pairwise Fisher's test did not show any significant increase in the incidence of any particular tumor type in the RF exposed groups as compared to the sham exposed group. Interestingly, while the incidences of hepatocellular carcinomas were similar in EMF and sham exposed groups, in both studies the incidences of liver adenomas in males decreased with increasing dose levels; the incidences in the high dose groups were statistically significantly different from those in the sham exposed groups. Comparison to published tumor rates in untreated mice revealed that the observed tumor rates were within the range of historical control data. In conclusion, the present study produced no evidence that the exposure of male and female B6C3F1 mice to wireless GSM and DCS radio frequency signals at a whole body absorption rate of up to 4.0 W/kg resulted in any adverse health effect or had any cumulative influence on the incidence or severity of neoplastic and non-neoplastic background lesions, and thus the study did not provide any evidence of RF possessing a carcinogenic potential. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17019729     DOI: 10.1002/bem.20283

Source DB:  PubMed          Journal:  Bioelectromagnetics        ISSN: 0197-8462            Impact factor:   2.010


  6 in total

1.  Answer to comments by A. Lerchl on "Radiofrequency electromagnetic fields (UMTS, 1,950 MHz) induce genotoxic effects in vitro in human fibroblasts but not in lymphocytes" published by C. Schwarz et al. 2008.

Authors:  Hugo W Rüdiger
Journal:  Int Arch Occup Environ Health       Date:  2008-05-15       Impact factor: 3.015

2.  Comments on "Radiofrequency electromagnetic fields (UMTS, 1,950 MHz) induce genotoxic effects in vitro in human fibroblasts but not in lymphocytes" by Schwarz et al. (Int Arch Occup Environ Health 2008: doi: 10.1007/s00420-008-0305-5).

Authors:  Alexander Lerchl
Journal:  Int Arch Occup Environ Health       Date:  2008-04-24       Impact factor: 3.015

3.  Life-Time Dosimetric Assessment for Mice and Rats Exposed in Reverberation Chambers of the 2-Year NTP Cancer Bioassay Study on Cell Phone Radiation.

Authors:  Yijian Gong; Myles Capstick; Sven Kuehn; Perry Wilson; John Ladbury; Galen Koepke; David L McCormick; Ronald L Melnick; Niels Kuster
Journal:  IEEE Trans Electromagn Compat       Date:  2017-03-17       Impact factor: 2.006

4.  Analysis of proteome response to the mobile phone radiation in two types of human primary endothelial cells.

Authors:  Reetta Nylund; Niels Kuster; Dariusz Leszczynski
Journal:  Proteome Sci       Date:  2010-10-18       Impact factor: 2.480

Review 5.  Are Exposures to Multiple Frequencies the Key to Future Radiofrequency Research?

Authors:  Zenon Sienkiewicz; Carolina Calderón; Kerry A Broom; Darren Addison; Amélie Gavard; Louise Lundberg; Myron Maslanyj
Journal:  Front Public Health       Date:  2017-12-08

Review 6.  The Contribution of In Vivo Mammalian Studies to the Knowledge of Adverse Effects of Radiofrequency Radiation on Human Health.

Authors:  Andrea Vornoli; Laura Falcioni; Daniele Mandrioli; Luciano Bua; Fiorella Belpoggi
Journal:  Int J Environ Res Public Health       Date:  2019-09-12       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.